- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
David Downs, San Francisco Chronicle
Bay Area-based advocacy group Americans for Safe Access is grading the medical marijuana programs of different states on how well they serve patients, and they’re ready to kill the buzz on New York becoming a medical marijuana state. New York Gov. Andrew Cuomo signed the bill into law Monday, the same day ASA gave The Empire State an “F+”.
The report uses a point system to grade each medical marijuana law on: a) patients’ rights and protection from discrimination, b) access to medicine, c) ease of navigation, and d) functionality. Among the reasons why New York’s medical pot program is a fail:
- patients can’t grown their own medicine, have a caregiver grow it, or collectively cultivate it
- New York prohibits patients from accessing cannabis (a plant) in plant form — only extracts like oils and edibles are allowed
- physicians specialized in cannabis cannot recommend it
- medical pot patients can still lose custody of their kids over their prescription
- medical pot patients can be jailed for DUI when they are sober
- medical pot patients can be fired for using the drug off-duty.
- medical pot patients can lose their housing over the medication
None of the 23 medical pot states got an “A” in ASA’s analysis, and “after years of failed implementation, state laws such as those in Connecticut, Delaware, and New Jersey remain inoperable for all practical purposes”, they write.
Here is every state’s grades, looks like Maine and Rhode Island are setting the curve:
Alaska (D-), Arizona (C+), California (B-), Colorado (C+), Connecticut (D), Delaware (D), Hawaii (D), Illinois (D), Maine (B), Maryland (D), Massachusetts (C), Michigan (C-), Minnesota (D-), Montana (D), Nevada (C), New Hampshire (D), New Jersey (D-), New Mexico (C), New York (F), Oregon (C+), Rhode Island (B), Vermont (C), Washington (B-), and the District of Columbia (D).